| abstract |
The present invention relates to novel CGRP inhibitors of general formula (I), wherein U, V, X, Y, R 1 , R 2 , R 3 and R 4 are as indicated herein, Tautomers, isomers, diastereomers, enantiomers, hydrates, mixtures, salts thereof, and hydrates of the salts, particularly physiologically acceptable salts thereof with inorganic or organic acids or bases A pharmaceutical agent comprising said compound; its use; and a process for its preparation. (I) |